Diabetic Neuropathy: Pathogenesis and Treatment. A Review

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of reconstructive microsurgery

• Publication date

  2004-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-2004-823112PMID 15088209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of membrane transport in metabolism and function of glutathione in mammals

  2005cited by this paper
• Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models

  2004cited by this paper
• Effect of Various Nerve Decompression Procedures on the Functions of Distal Limbs in Streptozotocin-Induced Diabetic Rats: Further Optimism in Diabetic Neuropathy

  2003cited by this paper
• Management of diabetic neuropathy.

  2003cited by this paper
• Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes.

  2003cited by this paper
• Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients.

  2002cited by this paper
• Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.

  2002cited by this paper
• An aldose reductase inhibitor reverses early diabetes‐induced changes in peripheral nerve function, metabolism, and antioxidative defense

  2002cited by this paper
• Preventing foot ulceration and amputation by decompressing peripheral nerves in patients with diabetic neuropathy.

  2002cited by this paper
• Hypoglycaemic neuropathy: microvascular changes due to recurrent hypoglycaemic episodes in rat sciatic nerve.

  2002cited by this paper
• Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP

  2002cited by this paper
• Dietary glutathione protects rats from diabetic nephropathy and neuropathy.

  2002cited by this paper
• Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives

  2002cited by this paper
• Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy.

  2002influential reference
• Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse.

  2002cited by this paper
• Thrombomodulin deficiency in human diabetic nerve microvasculature.

  2002cited by this paper
• GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats.

  2002cited by this paper
• Sciatic nerve lipoprotein lipase is reduced in streptozotocin-induced diabetes and corrected by insulin.

  2002influential reference
• Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?

  2002cited by this paper
• Status of current clinical trials in diabetic polyneuropathy.

  2002cited by this paper
• The effect of gamma-linolenic acid-alpha-lipoic acid on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.

  2001cited by this paper
• Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.

  2001cited by this paper
• Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy

  2001influential reference
• Molecular aspects of lipoic acid in the prevention of diabetes complications.

  2001influential reference
• Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes.

  2001cited by this paper
• Intravenous immunoglobulin therapy for diabetic amyotrophy.

  2001cited by this paper
• Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.

  2001cited by this paper
• Glutathione and α‐lipoate in diabetic rats: nerve function, blood flow and oxidative state

  2001cited by this paper
• Effects of an extracellular metal chelator on neurovascular function in diabetic rats

  2001cited by this paper
• EXTENDED NEUROLYSIS OF THE POSTERIOR TIBIAL NERVE TO IMPROVE SENSATION IN DIABETIC NEUROPATHIC FEET

  2001cited by this paper
• [Rapidly evolving diabetic mononeuritis multiplex. Favorable outcome after immunosuppressive treatment].

  2001cited by this paper
• Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic Polyneuropathy: A Randomized Controlled Trial

  2000cited by this paper
• Effects of DL-a-Lipoic Acid on Peripheral Nerve Conduction, Blood Flow, Energy Metabolism, and Oxidative Stress in Experimental Diabetic Neuropathy

  2000cited by this paper
• Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.

  2000cited by this paper
• Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy

  2000cited by this paper
• Treatment of diabetic neuropathy by decompression of the posterior tibial nerve.

  2000cited by this paper
• Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.

  2000cited by this paper
• Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy)

  2000cited by this paper
• Results of Decompression of Peripheral Nerves in Diabetics: A Prospective, Blinded Study

  2000cited by this paper
• Pancreas organ transplantation. Short and long-term results in terms of diabetes control.

  2000cited by this paper
• Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats.

  1999cited by this paper
• A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.

  1999cited by this paper
• Effects of chelator treatment on aorta and corpus cavernosum from diabetic rats.

  1999cited by this paper
• Only limited effects of aminoguanidine treatment on peripheral nerve function, (Na+,K+)-ATPase activity and thrombomodulin expression in streptozotocin-induced diabetic rats

  1999cited by this paper
• Alpha-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products.

  1999cited by this paper
• Diabetic neuropathy: pathogenesis and therapy.

  1999cited by this paper
• Diabetic neuropathy: scope of the syndrome.

  1999influential reference
• Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes.

  1999cited by this paper
• Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.

  1999cited by this paper
• Painful peripheral neuropathies.

  1999cited by this paper
• Neurotrophic factors in the therapy of diabetic neuropathy.

  1999influential reference
• Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy

  1999cited by this paper
• Lipoprotein lipase is expressed in cultured Schwann cells and functions in lipid synthesis and utilization.

  1998cited by this paper
• Beneficial effect of fetal islet grafting on development of late diabetic complications.

  1998cited by this paper
• The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)

  1998cited by this paper
• Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy.

  1998cited by this paper
• Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study.

  1998cited by this paper
• Effects of α-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids

  1998cited by this paper
• Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids.

  1998cited by this paper
• Protein kinase C activation and the development of diabetic complications.

  1998cited by this paper
• Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy

  1998cited by this paper
• A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy

  1998cited by this paper
• Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie.

  1997cited by this paper
• Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycaemic control provided by the pancreas

  1997cited by this paper
• Effects of dietary supplementation with arachidonic acid rich oils on nerve conduction and blood flow in streptozotocin-diabetic rats.

  1997cited by this paper
• Autoimmune diabetic neuropathy.

  1997cited by this paper
• The Roles of Oxidative Stress and Antioxidant Treatment in Experimental Diabetic Neuropathy

  1997cited by this paper
• Role of Neurotrophins in Diabetic Neuropathy and Treatment with Nerve Growth Factors

  1997cited by this paper
• Metabolic and Vascular Factors in the Pathogenesis of Diabetic Neuropathy

  1997cited by this paper
• Classification, Differential Diagnosis, and Staging of Diabetic Peripheral Neuropathy

  1997cited by this paper
• A Multicenter Study on the Prevalence of Diabetic Neuropathy in Italy

  1997cited by this paper
• Long‐term effects of pancreatic transplantation on diabetic neuropathy

  1997cited by this paper
• Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats.

  1997cited by this paper
• Diabetic neuropathies

  1997cited by this paper
• Diabetic neuropathy: prevalence, concordance between clinical and electrophysiological testing and impact of risk factors.

  1997cited by this paper
• Why do mitochondria synthesize fatty acids? Evidence for involvement in lipoic acid production.

  1997cited by this paper
• Effects of Treatment With the Antioxidant α-Lipoic Acid on Cardiac Autonomic Neuropathy in NIDDM Patients: A 4-month randomized controlled multicenter trial (DEKAN Study)

  1997cited by this paper
• Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats.

  1996cited by this paper
• Expression of NF-kappa B and I kappa B-alpha by aortic endothelium in an arterial injury model.

  1996cited by this paper
• Diabetic peripheral neuropathy: A clinicopathologic and immunohistochemical analysis of sural nerve biopsies

  1996cited by this paper
• Impact of pancreas transplantation on diabetic secondary complications and quality of life

  1996cited by this paper
• The role of endogenous nerve growth factor in human diabetic neuropathy

  1996cited by this paper
• [Tolrestat in the therapy of diabetic peripheral neuropathy: is this drug really useful?].

  1995cited by this paper
• Effect of 24 weeks of treatment with epalrestat, an aldose reductase inhibitor, on peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).

  1995cited by this paper
• Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy.

  1995cited by this paper
• Successful treatment of neuropathies in patients with diabetes mellitus.

  1995cited by this paper
• Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats

  1995cited by this paper
• Significance of fructose-induced protein oxidation and formation of advanced glycation end product.

  1995cited by this paper
• Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents.

  1995cited by this paper
• Phospholipid and Glutamic Acid Decarboxylase Autoantibodies in Diabetic Neuropathy

  1995cited by this paper
• Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant?

  1995cited by this paper
• Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy.

  1994cited by this paper
• Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: Dose-response considerations and independence from a myo-inositol mechanism

  1994cited by this paper
• The effect of systemically administered recombinant human nerve growth factor in healthy human subjects

  1994cited by this paper
• Early reduction in insulin-like growth factor gene expression in diabetic nerve.

  1994cited by this paper
• Effect of tarsal tunnel decompression in the streptozotocin‐induced diabetic rat

  1994cited by this paper
• Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus

  1994cited by this paper
• Diabetic neuropathy, nerve growth factor and other neurotrophic factors.

  1994cited by this paper
• Nerve biopsy findings in different patterns of proximal diabetic neuropathy

  1994cited by this paper

• Lower Extremity Nerve Decompression for Superimposed Peripheral Neuropathy in Diabetes: Awareness among Medical Professionals

  2025cites this paper
• Les formes douloureuses de la neuropathie diabétique

  2024cites this paper
• Painful forms of diabetic neuropathy.

  2024cites this paper
• Effect of resistance training on general health, happiness and its correlation with glycemic control in diabetic men with peripheral neuropathy

  2021influential citation
• Clinical Effect Analysis of Spinal Cord Electrical Stimulator Implantation for Diabetic Foot.

  2021cites this paper
• A new approach at diabetic foot treatment: Phosphodiesterase 5 inhibitors.

  2020cites this paper
• Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain

  2017cites this paper
• Nerve Decompression Models in Diabetic Rats

  2015cites this paper
• p75NTR-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte–endothelial crosstalk in diabetes after limb ischaemia

  2015cites this paper
• Association of Diabetic Neuropathy with Duration of Type 2 Diabetes and Glycemic Control

  2015cites this paper
• Clinical implication of elevated CA 19-9 level and the relationship with glucose control state in patients with type 2 diabetes

  2014cites this paper
• Chinese herbal medicine for diabetic peripheral neuropathy.

  2013cites this paper
• Thermal Threshold: Research Study on Small Fiber Dysfunction in Distal Diabetic Polyneuropathy

  2012cites this paper
• Treinamento físico reverte perda de neurônios do gânglio celíaco em ratos diabéticos (Diabetes mellitus)

  2011cites this paper
• Peripheral nerve surgery and research.

  2010cites this paper
• The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action.

  2010cites this paper
• Secretion and Peripheral Insulin Action The Role of Blood Vessels, Endothelial Cells, and Vascular Pericytes in Insulin

  2010cites this paper
• Peripheral neuropathy of the upper extremity: medical comorbidity that confounds common orthopedic pathology.

  2009cites this paper
• Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats.

  2009cites this paper
• Peripheral gene transfer of glial cell-derived neurotrophic factor ameliorates neuropathic deficits in diabetic rats.

  2009cites this paper
• Diabetic neuropathy: therapies on the horizon

  2009cites this paper
• Nerve Decompression Surgery as Treatment for Peripheral Diabetic Neuropathy: Literature Overview and Awareness Among Medical Professionals

  2009cites this paper
• Neuropathy: Metabolically-Induced

  2009cites this paper
• The Dellon Approach to Neurolysis in the Neuropathy Patient with Chronic Nerve Compression

  2008cites this paper
• [Genetic susceptibility to microangiopathy development in Type 1 diabetes mellitus].

  2008cites this paper
• Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients.

  2008cites this paper
• The four medial ankle tunnels: a critical review of perceptions of tarsal tunnel syndrome and neuropathy.

  2008cites this paper
• Effect of cartilage oligomeric matrix protein angiopoietin-1 on peripheral nerves in db/db diabetic mice.

  2008cites this paper
• Impact of cytokines on the pathomechanism of diabetic and alcoholic neuropathies.

  2007cites this paper
• Surgical treatment of superimposed nerve compressions in hepatitis C neuropathy

  2007cites this paper
• SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy.

  2007cites this paper
• Neurosurgical prevention of ulceration and amputation by decompression of lower extremity peripheral nerves in diabetic neuropathy: update 2006.

  2007cites this paper
• Diabetic neuropathy: pathogenesis and treatment.

  2007cites this paper
• Surgical approach to lower extremity nerve decompression in the patient with diabetic neuropathy

  2007cites this paper
• Recent clinical advances in diabetic polyneuropathy

  2006cites this paper
• Suppression of nNOS expression in rat enteric neurones by the receptor for advanced glycation end‐products

  2006cites this paper
• Insulin status differentially affects energy transduction in cerebral mitochondria from male and female rats.

  2006cites this paper
• Innovations in Peripheral Nerve Surgery

  2006cites this paper
• Comparison of Clinical Evaluation and Neurosensory Testing in the Early Diagnosis of Superimposed Entrapment Neuropathy in Diabetic Patients

  2006cites this paper
• Outcomes for peripheral nerve entrapment syndromes.

  2006cites this paper
• Diabetic neuropathy.

  2006cites this paper
• Effect of alloxan-diabetes and subsequent treatment with insulin on lipid/phospholipid composition of rat brain microsomes and mitochondria.

  2006cites this paper
• New developments in diabetic neuropathy

  2005cites this paper
• The Dellon Approach to Neurolysis in the Neuropathy Patient with Chronic Nerve Compression

  year unknowncites this paper